Compare Amphastar Pharmaceuticals Inc (AMPH) vs Rent the Runway Inc (RENT) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Rent the Runway (RENT) trades at $3.35, up 0.6% with a bullish technical signal. The company shows improving fundamentals with 2025 revenue reaching $306.2M and narrowing losses, though negative equity and high debt remain concerns. Recent leadership transition and Q1 2026 revenue growth of 29% indicate strategic shifts. Analyst consensus leans positive with 42% buy ratings but mixed earnings performance.

The outlook suggests potential upside based on low valuation multiples (P/E 0.45, P/S 0.19) and revenue growth trajectory, but risks include persistent negative cash flow, high leverage, and execution challenges under new management. Investors should weigh the discounted valuation against ongoing profitability concerns.